These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34029640)

  • 21. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Sun XH; Zhang S; Yang Z; Chen ZL; Yue SJ; Zhang S; Tang YP
    Chin J Integr Med; 2022 Jul; 28(7):650-660. PubMed ID: 35776293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Traditional Chinese Medicine on coronavirus disease 2019 in 92 patients: a retrospective study.
    Guihua XU; Feifei C; Wei Z; Yingen WU; Xiaorong C; Kehua S; Zhenwei W; Miaoyan S; Xing Z; Yunfei LU; Weian Y; Hua L; Xuan C
    J Tradit Chin Med; 2023 Jun; 43(3):582-587. PubMed ID: 37147761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials.
    Liang SB; Fang M; Liang CH; Lan HD; Shen C; Yan LJ; Hu XY; Han M; Robinson N; Liu JP
    Complement Ther Med; 2021 Aug; 60():102744. PubMed ID: 34091029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: A retrospective cohort study.
    Zhang X; Xue Y; Chen X; Wu JM; Su ZJ; Sun M; Liu LJ; Zhang YB; Zhang YL; Xu GH; Shi MY; Song XM; Lu YF; Chen XR; Zhang W; Chen Q
    J Integr Med; 2021 Jan; 19(1):36-41. PubMed ID: 33069626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.
    Wang Y; Lu C; Li H; Qi W; Ruan L; Bian Y; Shi H; Song H; Tu S; Zhang Y; Bai T; Cao R; Hong K; Li H; Liu L; Lu S; Rong N; Liu Y; Fang J; Shi J; Yang W; Zhao B; Yang Y; Zhao Y; Li S; Fan T; Rong P; Huang L
    J Ethnopharmacol; 2021 Sep; 277():113888. PubMed ID: 33529638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis.
    Li Z; Chen H; Zhang H; Li Y; Wang C; Bai L; Zhang W; Jiang Z
    ACS Omega; 2020 Dec; 5(47):30519-30530. PubMed ID: 33283100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19.
    Liu L; Shi F; Tu P; Chen C; Zhang M; Li X; Li C
    Medicine (Baltimore); 2021 Jan; 100(4):e24475. PubMed ID: 33530261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study.
    Qiao Y; Xu X; Zhou F; Wang K; Li M; Liu C; Chen Z; Yin P; Shi Y; Wang Y; Liu Q
    Phytomedicine; 2023 Apr; 112():154690. PubMed ID: 36780823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
    Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
    J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-Analysis.
    Zhou LP; Wang J; Xie RH; Pakhale S; Krewski D; Cameron DW; Wen SW
    J Altern Complement Med; 2021 Mar; 27(3):225-237. PubMed ID: 33252246
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
    Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
    Yan BH; Jiang ZW; Zeng JP; Tang JY; Ding H; Xia JL; Qin SR; Jin SC; Lu Y; Zhang N; Wang ZH; Li HY; Sang XY; Wu LN; Tang SY; Li Y; Tao MY; Wang QL; Wang JD; Xie HY; Chen QY; Yang SW; Hu NS; Yang JQ; Bao XX; Zhang Q; Yang XL; Jiang CY; Luo HY; Cai ZH; Yu SG
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):2993-3000. PubMed ID: 32726003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
    Zhang K; Tian M; Zeng Y; Wang L; Luo S; Xia W; Zhang X; Zha Y
    Complement Ther Med; 2020 Aug; 52():102473. PubMed ID: 32951723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: A retrospective cohort study.
    Shi MY; Sun SQ; Zhang W; Zhang X; Xu GH; Chen X; Su ZJ; Song XM; Liu LJ; Zhang YB; Zhang YL; Sun M; Chen Q; Xue Y; Lü H; Yuan WA; Chen XR; Lu YF
    J Integr Med; 2021 May; 19(3):226-231. PubMed ID: 33583756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
    Xin S; Cheng X; Zhu B; Liao X; Yang F; Song L; Shi Y; Guan X; Su R; Wang J; Xing L; Xu X; Jin L; Liu Y; Zhou W; Zhang D; Liang L; Yu Y; Yu R
    Biomed Pharmacother; 2020 Sep; 129():110500. PubMed ID: 32768975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice.
    Wu XV; Dong Y; Chi Y; Yu M; Wang W
    J Adv Nurs; 2021 Apr; 77(4):1635-1644. PubMed ID: 33174654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of the Timing of Traditional Chinese Medicine Therapy on the Therapeutic Effect and Prognosis of Severe Coronavirus Disease 2019].
    Zhang A; Li YP; Qiu M; Liu HB; Chen ZP; Wan P; Tao Y; Wang H; Wei DR; Li QT; Qin YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Aug; 42(4):521-530. PubMed ID: 32895105
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
    Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
    Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
    Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
    Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.